|
NPEPPS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.332750E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.515800E-01 |
| Normal-vs-Stage2 |
2.895000E-01 |
| Normal-vs-Stage3 |
4.415600E-03 |
| Normal-vs-Stage4 |
4.815600E-03 |
| Stage1-vs-Stage2 |
1.602790E-01 |
| Stage1-vs-Stage3 |
7.620200E-04 |
| Stage1-vs-Stage4 |
1.636960E-03 |
| Stage2-vs-Stage3 |
3.783000E-01 |
| Stage2-vs-Stage4 |
3.139800E-01 |
| Stage3-vs-Stage4 |
8.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.004760E-01 |
| Normal-vs-AfricanAmerican |
3.945200E-01 |
| Normal-vs-Asian |
1.384570E-01 |
| Caucasian-vs-AfricanAmerican |
9.597800E-01 |
| Caucasian-vs-Asian |
6.522600E-03 |
| AfricanAmerican-vs-Asian |
3.454200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.704500E-02 |
| Normal-vs-Female |
3.813400E-01 |
| Male-vs-Female |
4.022200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.850600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.155400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.763700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.025600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.159400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.568200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.704000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.153560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.067600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.126200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.729190E-01 |
| Normal-vs-Grade 2 |
8.104600E-01 |
| Normal-vs-Grade 3 |
2.616400E-02 |
| Normal-vs-Grade 4 |
3.563800000006E-05 |
| Grade 1-vs-Grade 2 |
1.310820E-01 |
| Grade 1-vs-Grade 3 |
7.598000E-03 |
| Grade 1-vs-Grade 4 |
1.022440E-02 |
| Grade 2-vs-Grade 3 |
7.024400E-03 |
| Grade 2-vs-Grade 4 |
1.22769999999495E-06 |
| Grade 3-vs-Grade 4 |
1.187740E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.822400E-01 |
| Normal-vs-ccB subtype |
9.513400E-01 |
| ccA subtype-vs-ccB subtype |
3.999400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.057400E-01 |
| Normal-vs-N1 |
5.447600E-01 |
| N0-vs-N1 |
7.187600E-01 |
|
|
